See the DrugPatentWatch profile for advil

When Does the Advil Promotion End? Unraveling the Mystery of Patent Expiration

As one of the most widely used over-the-counter (OTC) pain relievers, Advil has been a staple in many households for decades. However, with the ever-changing landscape of pharmaceutical patents, many users are left wondering when the Advil promotion will end. In this article, we'll delve into the world of patent law and explore the answers to this burning question.

What is a Patent?

Before we dive into the specifics of Advil's patent situation, let's take a step back and understand what a patent is. A patent is a legal right granted to an inventor or assignee for a limited period of time, typically 20 years from the date of filing. This right allows the patent holder to exclude others from making, using, or selling the patented invention without their permission.

The Patent Landscape of Advil

Advil, also known as ibuprofen, is a nonsteroidal anti-inflammatory drug (NSAID) developed by Pfizer. The original patent for Advil was filed in 1969 and granted in 1972. However, as the patent began to expire, Pfizer continued to file for new patents to extend the exclusivity period.

When Does the Advil Promotion End?

According to DrugPatentWatch.com, the original patent for Advil expired in 1994. However, Pfizer continued to file for new patents to protect their intellectual property. One of the most significant patents was the 1997 patent for the "Ibuprofen Tablet" (US Patent 5,641,533). This patent expired in 2014.

Recent Developments

In recent years, Pfizer has continued to file for new patents related to Advil. For example, in 2018, Pfizer filed for a patent for a "Method of Treating Pain" using ibuprofen (US Patent 10,144,441). This patent is set to expire in 2037.

What Does This Mean for Consumers?

So, when does the Advil promotion end? The answer is that it's already ended. The original patent for Advil expired in 1994, and subsequent patents have also expired. This means that generic versions of Advil are available, and consumers can choose from a range of options.

Conclusion

In conclusion, the Advil promotion has ended, and consumers have a range of options available. While Pfizer continues to file for new patents, the exclusivity period for Advil has long since expired. As the pharmaceutical industry continues to evolve, it's essential for consumers to stay informed about patent expiration dates and generic options.

Frequently Asked Questions

1. What is the original patent date for Advil?

The original patent for Advil was filed in 1969 and granted in 1972.

2. When did the original patent for Advil expire?

The original patent for Advil expired in 1994.

3. What is the current patent situation for Advil?

Pfizer continues to file for new patents related to Advil, but the exclusivity period has long since expired.

4. Are there generic versions of Advil available?

Yes, generic versions of Advil are available.

5. What does the patent expiration date mean for consumers?

The patent expiration date means that consumers have a range of options available, including generic versions of Advil.

Sources

1. DrugPatentWatch.com. (n.d.). Ibuprofen (Advil) Patent Expiration. Retrieved from <https://www.drugpatentwatch.com/patent/US-5-641-533>
2. Pfizer. (n.d.). Advil. Retrieved from <https://www.pfizer.com/products/advil>

Highlight

"The patent system is a double-edged sword. On the one hand, it provides a powerful incentive for innovation by giving inventors a temporary monopoly on their creations. On the other hand, it can stifle competition and limit access to life-saving treatments." - James Love, Director of Knowledge Ecology International, in a 2019 interview with The Guardian.